Cargando…
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers
BACKGROUND: Hepatocellular carcinoma (HCC) lacks effective treatments and has a poor prognosis. Therefore it is needed to develop more effective drug targets. Kinesin family member 11 (KIF11) has been reported to affect the progression of several cancers, and its high expression associates with the...
Autores principales: | Hu, Zhan-Dong, Jiang, Ying, Sun, Hong-Mei, Wang, Jing-wen, Zhai, Li-Li, Yin, Zhi-Qi, Yan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801104/ https://www.ncbi.nlm.nih.gov/pubmed/33490265 http://dx.doi.org/10.1155/2021/2676745 |
Ejemplares similares
-
KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020) -
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo
por: Gao, Zhenya, et al.
Publicado: (2021) -
[Retracted] KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo
por: Gao, Zhenya, et al.
Publicado: (2023) -
Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation
por: Huang, Xiaodong, et al.
Publicado: (2013) -
Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma
por: Zhu, Qiankun, et al.
Publicado: (2020)